Angela Brodie

9.7k total citations · 1 hit paper
132 papers, 7.8k citations indexed

About

Angela Brodie is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Angela Brodie has authored 132 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Genetics, 50 papers in Molecular Biology and 32 papers in Oncology. Recurrent topics in Angela Brodie's work include Estrogen and related hormone effects (102 papers), Pharmacogenetics and Drug Metabolism (18 papers) and Prostate Cancer Treatment and Research (17 papers). Angela Brodie is often cited by papers focused on Estrogen and related hormone effects (102 papers), Pharmacogenetics and Drug Metabolism (18 papers) and Prostate Cancer Treatment and Research (17 papers). Angela Brodie collaborates with scholars based in United States, United Kingdom and Canada. Angela Brodie's co-authors include Vincent C.O. Njar, Gauri Sabnis, Harry J. Brodie, Brian J. Long, S. E. Inkster, Luciana F. Macedo, Danijela Jelovac, V. Craig Jordan, William C. Schwarzel and Zhiyong Guo and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Angela Brodie

132 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion–Resistant Growth

2009 698 citations Zhiyong Guo, Xi Yang et al. Cancer Research profile →

Peers

Countries citing papers authored by Angela Brodie

Since Specialization

Citations

This map shows the geographic impact of Angela Brodie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Brodie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Brodie more than expected).

Fields of papers citing papers by Angela Brodie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Brodie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Brodie. The network helps show where Angela Brodie may publish in the future.

Co-authorship network of co-authors of Angela Brodie

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Brodie. A scholar is included among the top collaborators of Angela Brodie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Brodie. Angela Brodie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Aromatase inhibitors and breast cancer 2012 ·Hormone Molecular Biology and Clinical Investigation ·Saranya Chumsri, Angela Brodie	10
2	Functional Activation of the Estrogen Receptor-α and Aromatase by the HDAC Inhibitor Entinostat Sensitizes ER-Negative Tumors to Letrozole 2011 ·Cancer Research ·Gauri Sabnis, Olga Goloubeva, Saranya Chumsri, Nguyen Nguyen, Saraswati Sukumar, Angela Brodie	126
3	Aromatase inhibitors and xenograft studies 2011 ·Steroids ·Saranya Chumsri, Gauri Sabnis, Timothy R. Howes, Angela Brodie	13
4	Extending aromatase inhibitor sensitivity in hormone resistant breast cancer 2011 ·Hormone Molecular Biology and Clinical Investigation ·Angela Brodie, Saranya Chumsri, (unknown), Gauri Sabnis	3
5	Sensitivity to the Aromatase Inhibitor Letrozole Is Prolonged After a “Break” in Treatment 2010 ·Molecular Cancer Therapeutics ·Gauri Sabnis, Olga Goloubeva, Rabia A. Gilani, Luciana F. Macedo, Angela Brodie	21
6	Understanding Resistance to Endocrine Agents: Molecular Mechanisms and Potential for Intervention 2010 ·Clinical Breast Cancer ·Gauri Sabnis, Angela Brodie	21
7	Upregulation of AIB1, aromatase and ERα provides long-term estrogen-deprived human breast cancer cells with a mechanistic growth advantage for survival 2010 ·Hormone Molecular Biology and Clinical Investigation ·Syreeta L. Tilghman, Gauri Sabnis, Angela Brodie	11
8	A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion–Resistant Growth breakdown → 2009 ·Cancer Research ·Zhiyong Guo, Xi Yang, Feng Sun, Richeng Jiang, Douglas E. Linn, Hege Chen, Hegang Chen, Xiangtian Kong, Jonathan Melamed, Clifford G. Tepper, Hsing-Jien Kung, Angela Brodie, Joanne Edwards, Yun Qiu	698
9	Mammalian target of rapamycin (mTOR) as a target in human breast cancer cells that have acquired resistance to aromatase inhibitor letrozole 2006 ·Cancer Research ·Gauri Sabnis, Danijela Jelovac, Brian J. Long, Adam Schayowitz, Aashvini Belosay, Angela Brodie	4
10	Mechanistic Relationship between Androgen Receptor Polyglutamine Tract Truncation and Androgen-dependent Transcriptional Hyperactivity in Prostate Cancer Cells 2004 ·Journal of Biological Chemistry ·Qianben Wang, (unknown), Tadas S. Vasaitis, Angela Brodie, Joseph D. Fondell	40
11	Therapeutic Strategies Using the Aromatase Inhibitor Letrozole and Tamoxifen in a Breast Cancer Model 2004 ·JNCI Journal of the National Cancer Institute ·Brian J. Long, Danijela Jelovac, Venkatesh Handratta, Apinya Thiantanawat, Nicol Macpherson, Joseph Ragaz, Olga Goloubeva, Angela Brodie	102
12	Novel P45017α inhibitors: 17-(2′-oxazolyl)- and 17-(2′-thiazolyl)-androstene derivatives 2003 ·Steroids ·Na Zhu, (unknown), Xiaoping Lei, Venkatesh Handratta, Angela Brodie	38
13	The relationship between aromatase in primary breast tumors and response to treatment with aromatase inhibitors in advanced disease 2003 ·The Journal of Steroid Biochemistry and Molecular Biology ·Paul C. de Jong, Marinus A. Blankenstein, J.W.R. Nortier, P. H. Th. J. Slee, (unknown), (unknown), (unknown), (unknown), Geert H. Blijham, Jos H.H. Thijssen, Qing Lü, Danijela Jelovac, Angela Brodie	13
14	Aromatase expression in the human male 2001 ·Molecular and Cellular Endocrinology ·Angela Brodie, S. E. Inkster, Wei Yue	52
15	Aromatase inhibitors and their application in breast cancer treatmentâ 2000 ·Steroids ·Angela Brodie	88
16	Synthesis and in vitro activity of some epimeric 20α-hydroxy, 20-oxime and aziridine pregnene derivatives as inhibitors of human 17α-hydroxylase/c17,20-lyase and 5α-reductase 1998 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), Katsuya Kato, Liu Yang, Xin Wang, (unknown), Kirk Marat, Ivo Nnane, Angela Brodie	31
17	Aromatase inhibitors in advanced breast cancer: mechanism of action and clinical implications 1998 ·The Journal of Steroid Biochemistry and Molecular Biology ·Angela Brodie, Vincent C.O. Njar	73
18	Aromatase inhibitors in the treatment of breast cancer 1994 ·The Journal of Steroid Biochemistry and Molecular Biology ·Angela Brodie	68
19	Detection of aromatase and keratinocyte growth factor expression in breast tumors using reverse transcription-polymerase chain reaction 1993 ·The Journal of Steroid Biochemistry and Molecular Biology ·Robert D. Koos, (unknown), S. E. Inkster, Wei Yue, Angela Brodie	69
20	Expression of Aromatase Cytochrome P-450 in Premenopausal and Postmenopausal Human Ovaries: an Immunocytochemical Study* 1991 ·The Journal of Clinical Endocrinology & Metabolism ·S. E. Inkster, Angela Brodie	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact